This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

TIDES Europe Virtual 2020: Post-event Report

Share this article

This year saw the arrival of the first TIDES Europe Virtual on 11-13 November. Over 450 biotech professionals joined us online over the course of the three days.

The conference delivered over 130 sessions including, keynotes, presentations and discussions exploring topics ranging across development and delivery of peptides, oligos and mRNA therapeutics, green chemistry and updates on COVID-19 vaccines.

Whether or not you joined us for the conference this year, we invite you to join us as we review the best moments of the week, including the most popular keynotes and presentations, from peptide and oligo development to COVID-19 vaccines.

Click the image below or here to explore the report.

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

19 - 21 Mar 2024, Kyoto, Japan

Industry leaders and service providers share cutting-edge content and company expertise across the Oligonucleotide, Peptide, mRNA and Drug Delivery spectrum

Go to site